GenEdit: KIMCo jointly invests $1.7 mil. in US biotech firm GenEdit
The Korea Innovative Medicines Consortium (KIMCo) said Monday that it would conduct a joint investment project to help strengthen the Korean biopharmaceutical industry's global competitiveness.The consortium said that the joint investment project aims to create synergy in researching, developing, an
Read full article »
GenEdit is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases.
Read more